Tumor-infiltrating Immune Cells in H&E-stained Sections of Colorectal Cancer Tissue as a Reasonable Immunological Biomarker

Anticancer Res. 2018 Dec;38(12):6721-6727. doi: 10.21873/anticanres.13041.

Abstract

Background: The density of tumor-infiltrating lymphocytes has been reported to reflect the antitumor immune status, and many reports have shown that tumor-infiltrating CD8+ and total T-lymphocytes may be strong prognostic biomarkers in colorectal cancer. We previously reported that the density of tumor-infiltrating immune cells in hematoxylin and eosin (H&E)-stained sections may be an easily available prognostic biomarker. However, it remains unclear whether the density of tumor-infiltrating immune cells in H&E-stained sections accurately reflects the antitumor immune status.

Patients and methods: A total of 308 patients who underwent curative resection for stage II/III colorectal cancer were enrolled. The density of both tumor-infiltrating immune cells in H&E-stained sections and tumor-infiltrating lymphocyte subsets was assessed by immunohistochemistry.

Results: The density of tumor-infiltrating immune cells in H&E-stained sections was significantly and positively correlated with that of tumor-infiltrating CD4+/CD8+/total T-lymphocytes.

Conclusion: The density of tumor-infiltrating immune cells in H&E-stained sections may be a reasonable immunological biomarker.

Keywords: H&E; Tumor-infiltrating immune cells; colorectal cancer; immunological biomarker; tumor-infiltrating T-lymphocytes.

MeSH terms

  • Adult
  • Aged
  • Aged, 80 and over
  • Biomarkers, Tumor* / immunology
  • Colorectal Neoplasms / diagnosis
  • Colorectal Neoplasms / metabolism
  • Colorectal Neoplasms / pathology*
  • Female
  • Frozen Sections
  • Humans
  • Lymphocytes, Tumor-Infiltrating / metabolism
  • Lymphocytes, Tumor-Infiltrating / pathology
  • Lymphocytes, Tumor-Infiltrating / physiology*
  • Male
  • Middle Aged
  • Predictive Value of Tests
  • Staining and Labeling / methods*
  • Young Adult

Substances

  • Biomarkers, Tumor